Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
9009451 | Journal of the American Pharmacists Association | 2005 | 8 Pages |
Abstract
Universal claims for OTC-PTs of more than 99% laboratory accuracy and use as early as the first day of missed period, while cleared for use by the U.S. Food and Drug Administration, are ambiguous and inappropriate for many products, according to these data. The majority of products tested were found to detect only a small percentage of pregnancies on the first day of a missed menstrual period. Until more data become available on the actual clinical sensitivity of these products, pharmacists should advise consumers to be cautious in interpreting test results.
Related Topics
Health Sciences
Medicine and Dentistry
Public Health and Health Policy
Authors
Laurence A. (Professor, Director), Jaime M. (postdoctoral fellow), Sarah A. MPH, Marianna (medical student), Brittany B. (undergraduate student), William F. (Professor and Chairman),